Document is current
Any future updates will be listed below
-
Authors
Wang, Di
Lyu, Rong
Zhang, Yang
Hu, Wei-Juan
Ye, Zhao-Xiang
Xu, Peng-Ju https://orcid.org/0000-0002-0832-083X
-
Funding
Funding for this research was provided by:
Science and Technology Innovation Plan Of Shanghai Science and Technology Commission (22Y11910900)
Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A)
- License Information
-
More Information
Article History
Received: 30 May 2025
Revised: 9 August 2025
Accepted: 19 September 2025
First Online: 10 October 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Peng-Ju Xu.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: Some study subjects (61 patients) have been previously reported in “LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features” ().
:
